Tattooing and piercing: An underestimated issue for immunocompromised patients?

Presse Medicale

Volumn 42, Issue 5, 2013, Pages 791-794

  Kluger, Nicolas ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; INFLIXIMAB; INK; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE LEUKEMIA; ALLERGIC REACTION; ANKYLOSING SPONDYLITIS; ASEPSIS; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BACTERIAL ENDOCARDITIS; BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; BODY PIERCING; DISEASE TRANSMISSION; ECHTYMA GANGRENOSUM; EDITORIAL; ENTERITIS; FATIGUE; GANGRENE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; MYCOBACTERIOSIS; MYCOSIS; PATIENT SAFETY; PSEUDOMONAS AERUGINOSA; PSORIASIS; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; TATTOOING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ADULT; BODY PIERCING; DISEASE SUSCEPTIBILITY; DRUG CONTAMINATION; EQUIPMENT CONTAMINATION; FEMALE; FRANCE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; TATTOOING; WOUND INFECTION; YOUNG ADULT;

EID: 84878394709     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.01.001     Document Type: Editorial

References (23)

1. Laumann A.E., Derrick A.J. Tattoos and body piercings in the United States: a national data set. J Am Acad Dermatol 2006, 55:413-421.
2. Ifop pour Dimanche Ouest France. Les Français et les tatouages, Juillet 2010. , accessed 29 Nov. 2012. http://www.ifop.com/media/poll/1220-1-study_file.pdf.
3. Worp J., Boonstra A., Coutinho R.A., van den Hoek J.A. Tattooing, permanent makeup and piercing in Amsterdam; guidelines, legislation and monitoring. Euro Surveill 2006, 11:34-36.
4. Urbanus A.T., van den Hoek A., Boonstra A., van Houdt R., de Bruijn L.J., Heijman T., et al. People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands. PLoS One 2011, 6e24736.
5. O'Connor M.B., Phelan M.J. Should rheumatology patients on immunosuppressive medications be advised against getting tattoos?. Ir Med J 2012, 105:124.
6. O'Connor M.B., Phelan M.J. Should rheumatology patients on immunosuppressive medications be advised against getting piercing?. Ir Med J 2012, 105:124.
7. Kluger N., Guillot B. Complications des piercings. Ann Dermatol Venereol 2010, 137:153-158.
8. Tweeten S.S., Rickman L.S. Infectious complications of body piercing. Clin Infect Dis 1998, 26:735-740.
9. Guiard-Schmid J.B., Picard H., Slama L., Maslo C., Amiel C., Pialoux G., et al. Piercing and its infectious complications. A public health issue in France. Presse Med 2000, 29:1948-1956.
10. Armstrong M.L., DeBoer S., Cetta F. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health 2008, 43:217-225.
11. Pugatch D., Mileno M., Rich J.D. Possible transmission of human immunodeficiency virus type 1 from body piercing. Clin Infect Dis 1998, 26:767-768.
12. Kontoyiannis D.P., Chagua M.R., Ramirez I., Prieto V. Locally invasive auricular aspergillosis after ear piercing in a neutropenic patient with leukemia. Am J Hematol 2003, 73:296-297.
13. Razavi B., Schilling M. Chondritis attributable to Lactobacillus after ear piercing. Diagn Microbiol Infect Dis 2000, 37:75-76.
14. Assimakopoulos D., Tziouris D., Assimakopoulos A.D. Bilateral auricular perichondritis and diabetes mellitus. Otolaryngol Head Neck Surg 2009, 140:431-432.
15. Kluger N. Cutaneous complications related to permanent decorative tattooing. Expert Rev Clin Immunol 2010, 6:363-371.
16. Kluger N. Complications infectieuses cutanées associées au tatouage permanent. Med Mal Infect 2011, 41:115-122.
17. Kluger N. Acute complications of tattooing presenting in the ED. Am J Emerg Med 2012, 30:2055-2063.
18. Tendas A., Niscola P., Barbati R., Abruzzese E., Cuppelli L., Giovannini M., et al. Tattoo related pyoderma/ectyma gangrenous as presenting feature of relapsed acute myeloid leukaemia: an exceptionally rare observation. Injury 2011, 42:546-547.
19. Høgsberg T., Saunte D.M., Frimodt-Møller N., Serup J. Microbial status and product labelling of 58 original tattoo inks. J Eur Acad Dermatol Venereol 2013, 27:73-80.
20. Kluger N., Terru D., Godreuil S. Bacteriological and fungal survey of commercial tattoo inks used in daily practice in a tattoo parlour. J Eur Acad Dermatol Venereol 2011, 25(10):1230-1231.
21. Kennedy B.S., Bedard B., Younge M., Tuttle D., Ammerman E., Ricci J., et al. Outbreak of Mycobacterium chelonae infection associated with tattoo ink. N Engl J Med 2012, 367:1020-1024. [Epub ahead of print].
22. Kluger N., Debu A., Girard C., Bessis D., Guillot B. Psoriasis sur tatouage. Presse Med 2009, 38:338-339.
23. Bachmeyer C., Blum L., Petitjean B., Kemiche F., Pertuiset E. Granulomatous tattoo reaction in a patient treated with etanercept. J Eur Acad Dermatol Venereol 2007, 21:550-552.